Patents by Inventor Phillip GARFIN

Phillip GARFIN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HUMANIZED ANTI-LIV1 ANTIBODIES FOR THE TREATMENT OF BREAST CANCER
    Publication number: 20240076402
    Abstract: Methods for using anti-LIV1 antibodies, including drug conjugated anti-LIV1 antibodies, to inhibit proliferation of a LIV-1-expressing cell, as well as for the treatment of one or more diseases or disorders associated with LIV-1-expressing cells (e.g., a LIV-1-associated breast cancer), are provided.
    Type: Application
    Filed: March 7, 2023
    Publication date: March 7, 2024
    Inventors: Dana KENNEDY, Ana KOSTIC, Elizabeth CORWIN, Jonathan DRACHMAN, Peter HAUGHNEY, Baiteng ZHAO, Phillip GARFIN, Maria Corinna PALANCA-WESSELS, Oyewale O. ABIDOYE
  • HUMANIZED ANTI-LIV1 ANTIBODIES FOR THE TREATMENT OF CANCER
    Publication number: 20230330241
    Abstract: Methods for using anti-LIV1 antibodies and antibody-drug conjugates, including anti-LIV1 antibody-drug conjugates, to inhibit proliferation of a cell, such as a LIV1-expressing cell, as well as for the treatment of cancers, such as, e.g., LIV1-associated solid tumors and breast cancer (e.g., locally advanced or metastatic breast cancer), are provided.
    Type: Application
    Filed: February 17, 2023
    Publication date: October 19, 2023
    Inventors: Emily STEVENS, Hong LI, William HANLEY, Phillip GARFIN, Shawna HENGEL
  • HUMANIZED ANTI-LIV1 ANTIBODIES FOR THE TREATMENT OF CANCER
    Publication number: 20210030885
    Abstract: Methods for using anti-LIV1 antibodies and antibody-drug conjugates, including anti-LIV1 antibody-drug conjugates, to inhibit proliferation of a cell, such as a LIV1-expressing cell, as well as for the treatment of cancers, such as, e.g., LIV1-associated solid tumors and breast cancer (e.g., locally advanced or metastatic breast cancer), are provided.
    Type: Application
    Filed: July 21, 2020
    Publication date: February 4, 2021
    Inventors: Emily STEVENS, Hong LI, William HANLEY, Phillip GARFIN, Shawna HENGEL
  • HUMANIZED ANTI-LIV1 ANTIBODIES FOR THE TREATMENT OF BREAST CANCER
    Publication number: 20200283540
    Abstract: Methods for using anti-LIV1 antibodies, including dmg conjugated anti-LIV1 antibodies, to inhibit proliferation of a LIV-1-expressing cell, as well as for the treatment of one or more diseases or disorders associated with LIV-1-expressing cells (e.g., a LIV-1-associated breast cancer), are provided.
    Type: Application
    Filed: November 30, 2018
    Publication date: September 10, 2020
    Inventors: Dana KENNEDY, Ana KOSTIC, Elizabeth CORWIN, Jonathan DRACHMAN, Peter HAUGHNEY, Baiteng ZHAO, Phillip GARFIN, Corinna PALANCA-WESSELS, Oyewale O. ABIDOYE